Understanding the dual role of CXCL10 and the PI3K/Akt ‎signaling pathway in both cancer and immune cells provides valuable insights for the development ‎of therapeutic strategies aimed at either inhibiting cancer progression or enhancing the immune ‎response, thus highlighting potential opportunities for targeted cancer therapy.‎ The gene discussed is CXCL10; the disease is cancer.